Research services company IQVIA has unveiled new AI agents built using NVIDIA technology that are designed to enhance ...

Kite, unit today presented the latest results that demonstrate a 79% overall response rate (ORR) and 74% overall survival (OS ...

South Korea’s biosimilar drug developer Samsung Bioepis today presented the long-term safety data of Epysqli (eculizumab; ...

US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...

The US Food and Drug Administration (FDA) yesterday approved Nuvation Bio’s (NYSE: NUVB) Ibtrozi (taletrectinib), a kinase ...

French biotech Enterome has secured $19 million in private funding to accelerate development of its OncoMimics immunotherapy ...

Biogen has highlighted the growing role of felzartamab in its pipeline during a virtual investor seminar, spotlighting three ...

California-based clinical-stage biotech Juvena Therapeutics has entered a global licensing and multi-target research ...

Sino-American oncology company BeOne Medicines (Nasdaq: ONC) is presenting new clinical data from cornerstone hematology assets at the European Hematology Association (EHA) Congress.

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced new data from the pivotal AUGMENT-101 trial of Revuforj ...

Danish pharma major Novo Nordisk and privately-held Californian firm Deep Apple Therapeutics have announced a research ...

The UK’s medicines regulator has released a suite of new guidelines to steer companies through its upcoming decentralized ...